Compuestos de imidazopiridina
[Problem] A pharmaceutical composition for treating or preventing various cardiovascular diseases, which have sGC activities based on improvement of cGMP signals, is provided. [Means for Solution] It was found that imidazo[1,2-a]pyridine compounds having a carbamoyl group at the 3-position and a par...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KUROSAKI, Toshio ISHIOKA, Hiroki WATANABE, Tsubasa NOZAWA, Eisuke OHNE, Kazuhiko HACHIYA, Shunichiro SHIBATA, Hiroshi KOGA, Yuji HANAZAWA, Takeshi MIZOGUCHI, Ryo |
| description | [Problem] A pharmaceutical composition for treating or preventing various cardiovascular diseases, which have sGC activities based on improvement of cGMP signals, is provided. [Means for Solution] It was found that imidazo[1,2-a]pyridine compounds having a carbamoyl group at the 3-position and a particular cyclic group at the 8-position via a methyleneoxy group, or a salt thereof have sGC activation, and are useful as active ingredients of pharmaceutical compositions for treating or preventing various sGC-related cardiovascular diseases, in particular, peripheral arterial diseases, intermittent claudication, critical limb ischemia, hypertension, and pulmonary hypertension, thereby completing the present invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2644611TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2644611TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2644611TT33</originalsourceid><addsrcrecordid>eNrjZJB1zs8tKE0tLskvVkhJVcjMzUxJrMovyCzKTMnMS-RhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGuwUZmJiZmhoYhIcbGxKgBAPsaJO4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Compuestos de imidazopiridina</title><source>esp@cenet</source><creator>KUROSAKI, Toshio ; ISHIOKA, Hiroki ; WATANABE, Tsubasa ; NOZAWA, Eisuke ; OHNE, Kazuhiko ; HACHIYA, Shunichiro ; SHIBATA, Hiroshi ; KOGA, Yuji ; HANAZAWA, Takeshi ; MIZOGUCHI, Ryo</creator><creatorcontrib>KUROSAKI, Toshio ; ISHIOKA, Hiroki ; WATANABE, Tsubasa ; NOZAWA, Eisuke ; OHNE, Kazuhiko ; HACHIYA, Shunichiro ; SHIBATA, Hiroshi ; KOGA, Yuji ; HANAZAWA, Takeshi ; MIZOGUCHI, Ryo</creatorcontrib><description>[Problem] A pharmaceutical composition for treating or preventing various cardiovascular diseases, which have sGC activities based on improvement of cGMP signals, is provided. [Means for Solution] It was found that imidazo[1,2-a]pyridine compounds having a carbamoyl group at the 3-position and a particular cyclic group at the 8-position via a methyleneoxy group, or a salt thereof have sGC activation, and are useful as active ingredients of pharmaceutical compositions for treating or preventing various sGC-related cardiovascular diseases, in particular, peripheral arterial diseases, intermittent claudication, critical limb ischemia, hypertension, and pulmonary hypertension, thereby completing the present invention.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171129&DB=EPODOC&CC=ES&NR=2644611T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171129&DB=EPODOC&CC=ES&NR=2644611T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KUROSAKI, Toshio</creatorcontrib><creatorcontrib>ISHIOKA, Hiroki</creatorcontrib><creatorcontrib>WATANABE, Tsubasa</creatorcontrib><creatorcontrib>NOZAWA, Eisuke</creatorcontrib><creatorcontrib>OHNE, Kazuhiko</creatorcontrib><creatorcontrib>HACHIYA, Shunichiro</creatorcontrib><creatorcontrib>SHIBATA, Hiroshi</creatorcontrib><creatorcontrib>KOGA, Yuji</creatorcontrib><creatorcontrib>HANAZAWA, Takeshi</creatorcontrib><creatorcontrib>MIZOGUCHI, Ryo</creatorcontrib><title>Compuestos de imidazopiridina</title><description>[Problem] A pharmaceutical composition for treating or preventing various cardiovascular diseases, which have sGC activities based on improvement of cGMP signals, is provided. [Means for Solution] It was found that imidazo[1,2-a]pyridine compounds having a carbamoyl group at the 3-position and a particular cyclic group at the 8-position via a methyleneoxy group, or a salt thereof have sGC activation, and are useful as active ingredients of pharmaceutical compositions for treating or preventing various sGC-related cardiovascular diseases, in particular, peripheral arterial diseases, intermittent claudication, critical limb ischemia, hypertension, and pulmonary hypertension, thereby completing the present invention.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB1zs8tKE0tLskvVkhJVcjMzUxJrMovyCzKTMnMS-RhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGuwUZmJiZmhoYhIcbGxKgBAPsaJO4</recordid><startdate>20171129</startdate><enddate>20171129</enddate><creator>KUROSAKI, Toshio</creator><creator>ISHIOKA, Hiroki</creator><creator>WATANABE, Tsubasa</creator><creator>NOZAWA, Eisuke</creator><creator>OHNE, Kazuhiko</creator><creator>HACHIYA, Shunichiro</creator><creator>SHIBATA, Hiroshi</creator><creator>KOGA, Yuji</creator><creator>HANAZAWA, Takeshi</creator><creator>MIZOGUCHI, Ryo</creator><scope>EVB</scope></search><sort><creationdate>20171129</creationdate><title>Compuestos de imidazopiridina</title><author>KUROSAKI, Toshio ; ISHIOKA, Hiroki ; WATANABE, Tsubasa ; NOZAWA, Eisuke ; OHNE, Kazuhiko ; HACHIYA, Shunichiro ; SHIBATA, Hiroshi ; KOGA, Yuji ; HANAZAWA, Takeshi ; MIZOGUCHI, Ryo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2644611TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KUROSAKI, Toshio</creatorcontrib><creatorcontrib>ISHIOKA, Hiroki</creatorcontrib><creatorcontrib>WATANABE, Tsubasa</creatorcontrib><creatorcontrib>NOZAWA, Eisuke</creatorcontrib><creatorcontrib>OHNE, Kazuhiko</creatorcontrib><creatorcontrib>HACHIYA, Shunichiro</creatorcontrib><creatorcontrib>SHIBATA, Hiroshi</creatorcontrib><creatorcontrib>KOGA, Yuji</creatorcontrib><creatorcontrib>HANAZAWA, Takeshi</creatorcontrib><creatorcontrib>MIZOGUCHI, Ryo</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KUROSAKI, Toshio</au><au>ISHIOKA, Hiroki</au><au>WATANABE, Tsubasa</au><au>NOZAWA, Eisuke</au><au>OHNE, Kazuhiko</au><au>HACHIYA, Shunichiro</au><au>SHIBATA, Hiroshi</au><au>KOGA, Yuji</au><au>HANAZAWA, Takeshi</au><au>MIZOGUCHI, Ryo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Compuestos de imidazopiridina</title><date>2017-11-29</date><risdate>2017</risdate><abstract>[Problem] A pharmaceutical composition for treating or preventing various cardiovascular diseases, which have sGC activities based on improvement of cGMP signals, is provided. [Means for Solution] It was found that imidazo[1,2-a]pyridine compounds having a carbamoyl group at the 3-position and a particular cyclic group at the 8-position via a methyleneoxy group, or a salt thereof have sGC activation, and are useful as active ingredients of pharmaceutical compositions for treating or preventing various sGC-related cardiovascular diseases, in particular, peripheral arterial diseases, intermittent claudication, critical limb ischemia, hypertension, and pulmonary hypertension, thereby completing the present invention.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2644611TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Compuestos de imidazopiridina |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T02%3A10%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KUROSAKI,%20Toshio&rft.date=2017-11-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2644611TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |